EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bioactive galloylquinic acids from Copaifera lucens as dual inhibitors of SARS-CoV-2 Spike and RdRp proteins

Rasha M El-Morsi, Lamiaa A Al-Madboly, Jairo K Bastos, Shaimaa M Aboukhatwa, Samah A Nasr, Doaa A Ghareeb, Heba A Ramadan, Ivan Kushkevych, Mohamed A Abd El-Salam

Scientific Reports · 02.02.2026 · 16 (1)

DOI: 10.1038/s41598-025-25217-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 02.02.2026. Verfasst von Rasha M El-Morsi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Hauptthemen laut MEDLINE: Antiviral Agents, Quinic Acid, SARS-CoV-2, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistent global burden of SARS-CoV-2 underscores the urgent need for new antiviral agents. In this study, we evaluated the antiviral efficacy and underlying molecular mechanisms of galloylquinic acids (GQAs) extracted from Copaifera lucens leaves against SARS-CoV-2 using in vitro and in silico approaches. Cytotoxicity assays revealed a CC50 value of 387.7 µg/mL, while antiviral testing demonstrated an IC50 of 3.81 µg/mL, resulting in a high selective index (SI) of 102. Plaque reduction assays confirmed concentration-dependent virucidal effects, with up to 93% viral inhibition at 200 µg/mL. GQAs significantly disrupted key stages of the viral life cycle, including adsorption (80% inhibition at 250 µg/mL) and replication (up to 85.6% inhibition). Western blot analysis supported these findings, showing dose-dependent suppression of viral protein expression. Moreover, GQAs inhibited papain-like protease (PLpro) and the spike protein receptor binding domain (RBD) with notable potency, approaching the efficacy of reference antivirals remdesivir and molnupiravir. Molecular docking studies revealed strong binding affinities between the tri-substituted GQA and both the spike RBD and RNA-dependent RNA polymerase (RdRp), mediated by salt bridges, hydrogen bonding, and electrostatic interactions. These findings highlight GQAs from Copaifera lucens as promising multi-target antiviral candidates against SARS-CoV-2, exhibiting both direct virucidal effects and inhibition of viral entry and replication machinery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsQuinic AcidSARS-CoV-2Spike Glycoprotein, CoronavirusFabaceaeRNA-Dependent RNA PolymeraseMolecular Docking SimulationHumansAnimalsChlorocebus aethiopsVero CellsVirus ReplicationPlant ExtractsPlant Leaves

Stichwörter der Autor:innen

Copaifera lucensPhytotherapyAntiviral activityGalloylquinic acidsMolecular dockingRNA-dependent RNA polymeraseSARS-CoV-2

Substanzen

Antiviral AgentsQuinic AcidSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Plant ExtractsRNA-Dependent RNA Polymerase

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt. lamia.youssif@pharm.tanta.edu.eg.
  • Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, 14040-903, Brazil.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt.
  • Bio-Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, 21511, Egypt.
  • Bio-Screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, 21568, Egypt.

Zitieren

APA

El-Morsi, R. M., Al-Madboly, L. A., Bastos, J. K., Aboukhatwa, S. M., Nasr, S. A., Ghareeb, D. A., Ramadan, H. A., Kushkevych, I., & Abd El-Salam, M. A. (2026). Bioactive galloylquinic acids from Copaifera lucens as dual inhibitors of SARS-CoV-2 Spike and RdRp proteins. Scientific Reports, 16(1). https://doi.org/10.1038/s41598-025-25217-8

Vancouver

El-Morsi RM, Al-Madboly LA, Bastos JK, Aboukhatwa SM, Nasr SA, Ghareeb DA, et al. Bioactive galloylquinic acids from Copaifera lucens as dual inhibitors of SARS-CoV-2 Spike and RdRp proteins. Scientific Reports. 2026;16(1). doi:10.1038/s41598-025-25217-8

BibTeX
@article{ElMorsi2026,
  author = {El-Morsi, Rasha M and Al-Madboly, Lamiaa A and Bastos, Jairo K and Aboukhatwa, Shaimaa M and Nasr, Samah A and Ghareeb, Doaa A and Ramadan, Heba A and Kushkevych, Ivan and Abd El-Salam, Mohamed A},
  title = {Bioactive galloylquinic acids from Copaifera lucens as dual inhibitors of SARS-CoV-2 Spike and RdRp proteins},
  journal = {Scientific Reports},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.1038/s41598-025-25217-8}
}
Kostenlos starten →